Pharma community is encouraged to lend their views on key industry issues
Amsterdam, 09 October 2015: CPhI Worldwide, (#cphiww) organised by UBM EMEA, announces the second annual #CPhIChat, an industry-wide Tweetchat for pharma professionals and media working across the supply chain, aimed to stimulate conversations on key industry issues and facilitate shared knowledge building.
Taking place on Wednesday 14th October, from 2 to 4pm, the #CPhIChat will focus on the industry insights and forecasts delivered by CPhI’s expert panel in this year’s Annual Report. Now in it’s third successive year, the 2015 report features a collection of in-depth articles from 12 expert panel members who have given focus on a number of key issues currently surrounding pharma and projections for the future.
For 2015, the highlights and key predictions and trends affecting the industry include:
· Patent laws and regulatory changes
· QbD and continuous processing
· Biologics and steriles growth
CPhI will open the Tweetchat conversation by presenting key facts (with infographics) live at the show. This interactive initiative will link the media, some 36,000 people in attendance – via screens live at the show – and the wider global industry, who will be asked to weight-in on the discussion.
“Introducing #CPhIChat to the Worldwide event was a huge success last year and we are delighted to bring it back once more for further thought-provoking discussion on key issues surrounding the pharmaceutical industry. This platform is a great outlet for driving innovation and thought leadership alongside the exhibition, conferences and showcases.” Chris Kilbee, Group Director Pharma at CPhI.
CPhI encourages the entire industry to log into Twitter from 2 to 4 pm on Wednesday 14th October to join the debate by using the hashtags #CPhIChat and #CPhIWW. CPhI Worldwide attendees can follow the debate in real-time on the display screens that will be set-up throughout the exhibition. Alternatively, the debate can be followed by searching for the hashtags on Twitter from anywhere in the world. A summary report will be released after the show.
Finally, the Annual Report 2015 parts i and ii can be found online at: http://www.cphi.com/europe/networking/cphi-pharma-insights
Editors Note: Applied Clinical Trials is owned by UBM Americas.
-ENDS-
Notes to editors
About CPhI
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, South East Asia, Turkey and Russia and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.
For more information visit: www.cphi.com
The UBM EMEA annual schedule of Pharmaceutical events includes; CPhI, ICSE, P-MEC and InnoPack Worldwide (13-15 October 2015, IFEMA- Feria de Madrid, Spain); CPhI, P-MEC, ICSE and BioPh India (1-3 December, 2015 at the Bombay Convention and Exhibition Centre, Mumbai, India); InformEx (02-04 February, 2016); CPhI Russia (30 March – 01 April, 2016 at JSC VDNH (VVC), Pavilion 75, Hall A, Moscow); CPhI, P-MEC and Innopack South East Asia (06-08 April, 2016 at the Jakarta International Expo- Jakarta, Indonesia); CPhI, ICSE, P-MEC, BioPh and InnoPack Japan (20-22 April, 2016 at the Big Sight Exhibition Centre- Tokyo); CPhI Istanbul (1-3 June, 2016 at the ICC Istanbul Congress Center, Istanbul, Turkey); CPhI China and P-MEC (21-23 June, 2016 at SNIEC, Shanghai, China); CPhI Korea (23-25 August, 2016).
About UBM EMEA
UBM EMEA connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.